[CAS NO. 68252-28-8] (R)-Oxiracetam
PRODUCTS SPECIFICATIONS [68252-28-8]
DESCRIPTION [68252-28-8]
Overview
| MDL | MFCD01688364 |
|---|---|
| Molecular Weight | 158.16 |
| Molecular Formula | C6H10N2O3 |
| SMILES | O=C(N)CN1C(C[C@@H](O)C1)=O |
Summary
(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant. IC50 value: Target: nootropic drug Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
H 2 O : ≥ 50 mg/mL ( 316.14 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.3227 mL | 31.6136 mL | 63.2271 mL |
| 5 mM | 1.2645 mL | 6.3227 mL | 12.6454 mL |
| 10 mM | 0.6323 mL | 3.1614 mL | 6.3227 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (632.27 mM); Clear solution; Need ultrasonic
References
- [1] Malykh AG, et al. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. 2010 Feb 12;70(3):287-312.
- [2] Valzelli L, et al. Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants. Methods Find Exp Clin Pharmacol. 1986 Jun;8(6):337-41.
Synonyms
